April 20, 2007
Nanogen Inc, developer of advanced diagnostic products, has obtained a United States Government Service Administration (GSA) Schedule contract that applies to the company’s NanoChip 400 microarray instrument and reagents.
The contract will let the company be listed on an approved GSA Schedule and sell its NanoChip products directly to government agencies, military hospitals, and Veteran’s Administration hospitals.
The inclusion on the list allows government customers to obtain approved pricing and license terms from a pre-qualified vendor.
The NanoChip®400 is an automated multiplexing platform that laboratories use to detect genetic sequences. Tests can be performed using reagents supplied by Nanogen, or laboratories can develop a variety of in-house assays.
More information can be found on the company’s Web site.
